UK markets closed

BerGenBio ASA (BGBIO.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
11.57+0.06 (+0.54%)
At close: 04:25PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-154,520
-190,401
-302,122
-309,364
-257,029
Depreciation & amortisation
321
223
883
1,312
726
Stock-based compensation
3,258
3,135
3,466
7,113
7,412
Change in working capital
-30,781
-33,389
9,210
61
17,506
Other working capital
-192,316
-225,101
-288,231
-303,340
-234,357
Other non-cash items
-2,812
-3,055
-2,949
-3,130
-3,614
Net cash provided by operating activities
-192,316
-225,101
-288,231
-303,340
-234,290
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-
-67
Other investing activities
-
-
-
-
1
Net cash used for investing activities
2,979
3,055
3,248
3,130
3,548
Net change in cash
35,443
2,838
-282,080
-284,216
468,765
Cash at beginning of period
72,994
150,803
436,646
721,641
253,586
Cash at end of period
108,439
156,421
150,803
436,646
721,641
Free cash flow
Operating cash flow
-192,316
-225,101
-288,231
-303,340
-234,290
Capital expenditure
-
-
-
-
-67
Free cash flow
-192,316
-225,101
-288,231
-303,340
-234,357